{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:11:58Z","timestamp":1794852718350,"version":"4.9.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL103866"],"award-info":[{"award-number":["R01 HL103866"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HL147823"],"award-info":[{"award-number":["P01 HL147823"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL134622"],"award-info":[{"award-number":["T32 HL134622"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM007250"],"award-info":[{"award-number":["T32 GM007250"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P30ES007048"],"award-info":[{"award-number":["P30ES007048"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL133169"],"award-info":[{"award-number":["R01 HL133169"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL148110"],"award-info":[{"award-number":["R01 HL148110"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WI 5229\/1-1"],"award-info":[{"award-number":["WI 5229\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1038\/s41591-023-02793-8","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T12:02:21Z","timestamp":1708344141000},"page":"424-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk"],"prefix":"10.1038","volume":"30","author":[{"given":"Marc","family":"Ferrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6455-8228","authenticated-orcid":false,"given":"Zeneng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4946-4271","authenticated-orcid":false,"given":"Xinmin S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6952-5038","authenticated-orcid":false,"given":"Marco","family":"Witkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"DiDonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Hilser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4883-9318","authenticated-orcid":false,"given":"Jaana A.","family":"Hartiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5646-3237","authenticated-orcid":false,"given":"Arash","family":"Haghikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-3355","authenticated-orcid":false,"given":"Tomas","family":"Cajka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-8928","authenticated-orcid":false,"given":"Oliver","family":"Fiehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2407-769X","authenticated-orcid":false,"given":"Naseer","family":"Sangwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4340-2523","authenticated-orcid":false,"given":"Ilja","family":"Demuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Steinhagen-Thiessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-3203","authenticated-orcid":false,"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"W. H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2384-5239","authenticated-orcid":false,"given":"Hooman","family":"Allayee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7124-6639","authenticated-orcid":false,"given":"Stanley L.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"2793_CR1","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/CIRCULATIONAHA.123.064226","volume":"147","author":"SS Virani","year":"2023","unstructured":"Virani, S. S. et al. Heart Disease and Stroke Statistics\u20142023 update: a report from the American Heart Association. Circulation 147, 1772\u20131782 (2023).","journal-title":"Circulation"},{"key":"2793_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino, R. B. et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117, 743\u2013753 (2008).","journal-title":"Circulation"},{"key":"2793_CR3","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1056\/NEJMoa1701488","volume":"376","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Cardiovascular efficacy and safety of bococizumab in high-risk patients. N. Engl. J. Med. 376, 1527\u20131539 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2793_CR4","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine, M. S. et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N. Engl. J. Med. 376, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2793_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.118.034645","volume":"138","author":"AD Pradhan","year":"2018","unstructured":"Pradhan, A. D., Aday, A. W., Rose, L. M. & Ridker, P. M. Residual inflammatory risk on treatment with PCSK9 inhibition and statin therapy. Circulation 138, 141\u2013149 (2018).","journal-title":"Circulation"},{"key":"2793_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.118.034032","volume":"138","author":"EA Bohula","year":"2018","unstructured":"Bohula, E. A. et al. Inflammatory and cholesterol risk in the FOURIER trial. Circulation 138, 131\u2013140 (2018).","journal-title":"Circulation"},{"key":"2793_CR7","doi-asserted-by":"crossref","unstructured":"Makarov, M. V., Trammell, S. A. J. & Migaud, M. E. The chemistry of the vitamin B3 metabolome. Biochem. Soc. Trans. 47, 131\u2013147 (2019).","DOI":"10.1042\/BST20180420"},{"key":"2793_CR8","doi-asserted-by":"crossref","unstructured":"Wan, P., Moat, S. & Anstey, A. Pellagra: a review with emphasis on photosensitivity. Br. J. Dermatol. 164, 1188\u20131200 (2011).","DOI":"10.1111\/j.1365-2133.2010.10163.x"},{"key":"2793_CR9","unstructured":"Dietary Reference Intakes: The Essential Guide to Nutrient Requirements (eds Otten, J. J., Hellwig, J. P. & Meyers, L. D) (The National Academies Press, 2006)."},{"key":"2793_CR10","doi-asserted-by":"publisher","unstructured":"Stierman, B. et al. National Health and Nutrition Examination Survey 2017\u2013March 2020 Prepandemic Data Files\u2014Development of Files and Prevalence Estimates for Selected Health Outcomes. National Health Statistics Reports 158, https:\/\/doi.org\/10.15620\/cdc:106273 (2021).","DOI":"10.15620\/cdc:106273"},{"key":"2793_CR11","doi-asserted-by":"crossref","unstructured":"Stamler, J. The Coronary Drug Project\u2014findings with regard to estrogen, dextrothyroxine, clofibrate and niacin. Adv. Exp. Med. Biol. 82, 52\u201375 (1977).","DOI":"10.1007\/978-1-4613-4220-5_6"},{"key":"2793_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/eurheartj\/eht064","volume":"34","author":"U Landmesser","year":"2013","unstructured":"Landmesser, U. The difficult search for a \u2018partner\u2019 of statins in lipid-targeted prevention of vascular events: the re-emergence and fall of niacin. Eur. Heart J. 34, 1254\u20131257 (2013).","journal-title":"Eur. Heart J."},{"key":"2793_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1056\/NEJMe1406410","volume":"371","author":"DM Lloyd-Jones","year":"2014","unstructured":"Lloyd-Jones, D. M. Niacin and HDL cholesterol\u2014time to face facts. N. Engl. J. Med. 371, 271\u2013273 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2793_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa1300955","volume":"371","author":"MJ Landray","year":"2014","unstructured":"Landray, M. J., Haynes, R. & Hopewell, J. C. Effects of extended-release niacin with laropiprant in high-risk patients. N. Engl. J. Med. 371, 203\u2013212 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2793_CR15","doi-asserted-by":"crossref","unstructured":"Boden, W. et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365, 2255\u20132267 (2011).","DOI":"10.1056\/NEJMoa1107579"},{"key":"2793_CR16","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1016\/j.jacc.2018.04.020","volume":"71","author":"DJA Jenkins","year":"2018","unstructured":"Jenkins, D. J. A. et al. Supplemental vitamins and minerals for CVD prevention and treatment. J. Am. Coll. Cardiol. 71, 2570\u20132584 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2793_CR17","doi-asserted-by":"crossref","unstructured":"Li, X. S. et al. Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. JCI Insight 3, e99096 (2018).","DOI":"10.1172\/jci.insight.99096"},{"key":"2793_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201365 (2011).","journal-title":"Nature"},{"key":"2793_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","volume":"180","author":"I Nemet","year":"2020","unstructured":"Nemet, I. et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell 180, 862\u2013877 (2020).","journal-title":"Cell"},{"key":"2793_CR20","doi-asserted-by":"crossref","unstructured":"Witkowski, M. et al. The artificial sweetener erythritol and cardiovascular event risk. Nat. Med. 29, 710\u2013718 (2023).","DOI":"10.1038\/s41591-023-02223-9"},{"key":"2793_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0021-9258(18)81324-2","volume":"238","author":"D Abelson","year":"1962","unstructured":"Abelson, D., Boyle, A. & Seligson, H. Identification of N\u2032-methyl-4-pyridone-3-carboxamide in human plasma. J. Biol. Chem. 238, 717\u2013718 (1962).","journal-title":"J. Biol. Chem."},{"key":"2793_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/0091270007300264","volume":"47","author":"R Menon","year":"2007","unstructured":"Menon, R. et al. Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites. J. Clin. Pharm. 47, 681\u2013688 (2007).","journal-title":"J. Clin. Pharm."},{"key":"2793_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GTEx Consortium.","year":"2013","unstructured":"GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"2793_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"B Sun","year":"2018","unstructured":"Sun, B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73\u201379 (2018).","journal-title":"Nature"},{"key":"2793_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41467-021-27850-z","volume":"13","author":"G Gudjonsson","year":"2022","unstructured":"Gudjonsson, G. et al. A genome-wide association study of serum proteins reveals shared loci with common diseases. Nat. Comm. 13, 480 (2022).","journal-title":"Nat. Comm."},{"key":"2793_CR26","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1161\/hq1001.096625","volume":"21","author":"HM Dansky","year":"2001","unstructured":"Dansky, H. M. et al. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler. Thromb. Vasc. Biol. 21, 1662\u20131667 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2793_CR27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1172\/JCI11871","volume":"107","author":"MI Cybulsky","year":"2001","unstructured":"Cybulsky, M. I. et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107, 1255\u20131262 (2001).","journal-title":"J. Clin. Invest."},{"key":"2793_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"B Sun","year":"2023","unstructured":"Sun, B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"2793_CR29","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41588-022-01233-6","volume":"54","author":"K Aragam","year":"2022","unstructured":"Aragam, K. et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat. Genet. 54, 1803\u20131815 (2022).","journal-title":"Nat. Genet."},{"key":"2793_CR30","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/eurheartj\/ehaa1040","volume":"42","author":"J Hartiala","year":"2021","unstructured":"Hartiala, J. et al. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. Eur. Heart J. 42, 919\u2013933 (2021).","journal-title":"Eur. Heart J."},{"key":"2793_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","volume":"611","author":"A Mishra","year":"2022","unstructured":"Mishra, A. et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature 611, 115\u2013123 (2022).","journal-title":"Nature"},{"key":"2793_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/M18-2478","volume":"170","author":"F Chen","year":"2019","unstructured":"Chen, F. et al. Association among dietary supplement use, nutrient intake, and mortality among U.S. adults. Ann. Intern. Med. 170, 604\u2013613 (2019).","journal-title":"Ann. Intern. Med."},{"key":"2793_CR33","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1111\/1541-4337.12491","volume":"18","author":"J Tyler","year":"2019","unstructured":"Tyler, J. et al. Global concerns with B vitamin statuses: biofortification, fortification, hidden hunger, interactions, and toxicity. Compr. Rev. Food Sci. Food Saf. 18, 1968\u20131964 (2019).","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"2793_CR34","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren, F. L. J. et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 42, 3227\u20133337 (2021).","journal-title":"Eur. Heart J."},{"key":"2793_CR35","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1001\/jama.2022.8970","volume":"327","author":"CM Mangione","year":"2022","unstructured":"Mangione, C. M. et al. Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer: US Preventive Services Task Force recommendation statement. JAMA 327, 2326\u20132333 (2022).","journal-title":"JAMA"},{"key":"2793_CR36","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy, S. M. et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 73, e285\u2013e350 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2793_CR37","doi-asserted-by":"crossref","unstructured":"Teo, K. K. et al. Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease the atherothrombosis intervention in metabolic syndrome with low HDL\/high triglycerides: impact on global health outcome (AIM-HIGH) trial. Stroke 44, 2688\u20132693 (2013).","DOI":"10.1161\/STROKEAHA.113.001529"},{"key":"2793_CR38","unstructured":"US Department of Agriculture Food Data Central. https:\/\/fdc.nal.usda.gov\/"},{"key":"2793_CR39","unstructured":"US Department of Agriculture Center for Nutrition Policy and Promotion. https:\/\/www.fns.usda.gov\/cnpp"},{"key":"2793_CR40","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","volume":"28","author":"YS Elhassan","year":"2019","unstructured":"Elhassan, Y. S. et al. Nicotinamide riboside augments the aged human skeletal muscle NAD + metabolome and induces article nicotinamide riboside augments the aged human skeletal muscle NAD + metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 28, 1717\u20131728 (2019).","journal-title":"Cell Rep."},{"key":"2793_CR41","doi-asserted-by":"publisher","first-page":"12948","DOI":"10.1038\/ncomms12948","volume":"7","author":"SAJ Trammell","year":"2016","unstructured":"Trammell, S. A. J. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016).","journal-title":"Nat. Commun."},{"key":"2793_CR42","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.abe9985","volume":"373","author":"M Yoshino","year":"2021","unstructured":"Yoshino, M., Yohino, J., Kayser, B., Imai, S.-I. & Klein, S. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 373, 1224\u20131229 (2021).","journal-title":"Science"},{"key":"2793_CR43","doi-asserted-by":"crossref","unstructured":"Yi, L. et al. The efficacy and safety of \u03b2-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience 45, 29\u201343 (2022).","DOI":"10.1007\/s11357-022-00705-1"},{"key":"2793_CR44","unstructured":"Chini, E. Effects of vitamin B3 derivative nicotinamide riboside (NR) in bone, skeletal muscle and metabolic functions in aging. NCT03818802"},{"key":"2793_CR45","unstructured":"Slow age: interventions to slow aging in humans. NCT05593939"},{"key":"2793_CR46","unstructured":"The effect of NAD supplementation on brain vascular health in aging. NCT05483465"},{"key":"2793_CR47","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","volume":"9","author":"CR Martens","year":"2018","unstructured":"Martens, C. R. et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat. Commun. 9, 1286 (2018).","journal-title":"Nat. Commun."},{"key":"2793_CR48","doi-asserted-by":"crossref","unstructured":"Cant\u00f3, C., Menzies, K. J. & Auwerx, J. NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 22, 31\u201353 (2015).","DOI":"10.1016\/j.cmet.2015.05.023"},{"key":"2793_CR49","doi-asserted-by":"crossref","unstructured":"Lenglet, A. et al. N-methyl-2-pyridone-5-carboxamide (2PY)\u2014major metabolite of nicotinamide: an update on an old uremic toxin. Toxins (Basel) 8, 339 (2016).","DOI":"10.3390\/toxins8110339"},{"key":"2793_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ajcn\/34.3.423","volume":"34","author":"M Horwitt","year":"1981","unstructured":"Horwitt, M., Harper, A. & Henderson, L. Niacin\u2013tryptophan relationships for evaluating niacin equivalents. Am. J. Clin. Nutr. 34, 423\u2013427 (1981).","journal-title":"Am. J. Clin. Nutr."},{"key":"2793_CR51","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1021\/acs.jmedchem.7b01254","volume":"61","author":"R Pellicciari","year":"2018","unstructured":"Pellicciari, R. et al. \u03b1-Amino-\u03b2-carboxymuconate-\u03f5-semialdehyde decarboxylase (ACMSD) inhibitors as novel modulators of de novo nicotinamide adenine dinucleotide (NAD+) biosynthesis. J. Med. Chem. 61, 745\u2013759 (2018).","journal-title":"J. Med. Chem."},{"key":"2793_CR52","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41586-018-0645-6","volume":"563","author":"E Katsyuba","year":"2018","unstructured":"Katsyuba, E. et al. De novo NAD+ synthesis enhances mitochondrial function and improves health. Nature 563, 354\u2013359 (2018).","journal-title":"Nature"},{"key":"2793_CR53","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41467-022-29143-5","volume":"13","author":"X Yin","year":"2022","unstructured":"Yin, X. et al. Genome-wide association studies of metabolites in Finnish men identify disease-relevant loci. Nat. Comm. 13, 1664 (2022).","journal-title":"Nat. Comm."},{"key":"2793_CR54","doi-asserted-by":"crossref","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 7, e34408 (2018).","DOI":"10.7554\/eLife.34408"},{"key":"2793_CR55","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2793_CR56","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nri2156","volume":"7","author":"K Ley","year":"2007","unstructured":"Ley, K., Laudanna, C., Cybulsky, M. I. & Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678\u2013689 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"2793_CR57","first-page":"2525","volume":"117","author":"P Libby","year":"2021","unstructured":"Libby, P. Inflammation during the life cycle of the atherosclerotic plaque. Cardiovasc. Res. 117, 2525\u20132536 (2021).","journal-title":"Cardiovasc. Res."},{"key":"2793_CR58","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1172\/JCI116778","volume":"92","author":"N Marui","year":"1993","unstructured":"Marui, N. et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92, 1866\u20131874 (1993).","journal-title":"J. Clin. Invest."},{"key":"2793_CR59","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/0006-291X(92)91234-H","volume":"187","author":"R Pigott","year":"1992","unstructured":"Pigott, R., Dillon, L. P., Hemingway, I. H. & Gearing, A. J. H. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun. 187, 584\u2013589 (1992).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2793_CR60","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1161\/hc3701.095949","volume":"104","author":"S Blankenberg","year":"2001","unstructured":"Blankenberg, S. et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104, 1336\u20131342 (2001).","journal-title":"Circulation"},{"key":"2793_CR61","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth, R. A. et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576\u2013585 (2013).","journal-title":"Nat. Med."},{"key":"2793_CR62","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1161\/CIRCULATIONAHA.109.881581","volume":"122","author":"ML Brennan","year":"2010","unstructured":"Brennan, M. L. et al. Comprehensive peroxidase-based hematologic profiling for the prediction of 1-year myocardial infarction and death. Circulation 122, 70\u201379 (2010).","journal-title":"Circulation"},{"key":"2793_CR63","doi-asserted-by":"publisher","first-page":"e030097","DOI":"10.1136\/bmjopen-2019-030097","volume":"9","author":"M K\u00f6nig","year":"2019","unstructured":"K\u00f6nig, M. et al. Cohort profile: role of lipoproteins in cardiovascular disease\u2014the LipidCardio study. BMJ Open 9, e030097 (2019).","journal-title":"BMJ Open"},{"key":"2793_CR64","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker, L. A. et al. New creatinine- and cystatin C\u2013based equations to estimate GFR without race. N. Engl. J. Med. 385, 1737\u20131749 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2793_CR65","doi-asserted-by":"crossref","unstructured":"STROBE statement\u2014checklist of items that should be included in reports of observational studies (STROBE initiative). Int. J. Public Health 53, 3\u20134 (2008).","DOI":"10.1007\/s00038-007-0239-9"},{"key":"2793_CR66","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"T Pluskal","year":"2010","unstructured":"Pluskal, T., Castillo, S., Villar-Briones, A. & Ore\u0161i\u010d, M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 11, 395 (2010).","journal-title":"BMC Bioinformatics"},{"key":"2793_CR67","doi-asserted-by":"publisher","first-page":"e1003123","DOI":"10.1371\/journal.pcbi.1003123","volume":"9","author":"S Li","year":"2013","unstructured":"Li, S. et al. Predicting network activity from high throughput metabolomics. PLoS Comput. Biol. 9, e1003123 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"2793_CR68","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong, J. et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 46, W486\u2013W494 (2018).","journal-title":"Nucleic Acids Res."},{"key":"2793_CR69","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/eurheartj\/ehs424","volume":"34","author":"M Magnusson","year":"2013","unstructured":"Magnusson, M. et al. A diabetes-predictive amino acid score and future cardiovascular disease. Eur. Heart J. 34, 1982\u20131989 (2013).","journal-title":"Eur. Heart J."},{"key":"2793_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41598-018-34245-6","volume":"8","author":"X Du","year":"2018","unstructured":"Du, X. et al. Relationships between circulating branched chain amino acid concentrations and risk of adverse cardiovascular events in patients with STEMI treated with PCI. Sci. Rep. 8, 6\u201313 (2018).","journal-title":"Sci. Rep."},{"key":"2793_CR71","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5539\/gjhs.v4n6p170","volume":"4","author":"K Soda","year":"2012","unstructured":"Soda, K., Kano, Y. & Chiba, F. Food polyamine and cardiovascular disease\u2014an epidemiological study. Glob. J. Health Sci. 4, 170\u2013178 (2012).","journal-title":"Glob. J. Health Sci."},{"key":"2793_CR72","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1021\/ac902616k","volume":"82","author":"R Lang","year":"2010","unstructured":"Lang, R. et al. Development of a hydrophilic liquid interaction chromatography\u2013high-performance liquid chromatography\u2013tandem mass spectrometry based stable isotope dilution analysis and pharmacokinetic studies on bioactive pyridines in human plasma and urine after coffee. Anal. Chem. 82, 1486\u20131497 (2010).","journal-title":"Anal. Chem."},{"key":"2793_CR73","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bmcl.2018.01.058","volume":"28","author":"S Ruf","year":"2018","unstructured":"Ruf, S. et al. Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase. Bioorg. Med. Chem. Lett. 28, 922\u2013925 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2793_CR74","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).","journal-title":"Gigascience"},{"key":"2793_CR75","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190\u20132191 (2010).","journal-title":"Bioinformatics"},{"key":"2793_CR76","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1093\/nar\/gkr1255","volume":"40","author":"F Begum","year":"2012","unstructured":"Begum, F., Ghosh, D., Tseng, G. C. & Feingold, E. Comprehensive literature review and statistical considerations for GWAS meta-analysis. Nucleic Acids Res. 40, 3777\u20133784 (2012).","journal-title":"Nucleic Acids Res."},{"key":"2793_CR77","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1742-4658.2007.05635.x","volume":"274","author":"L Pucci","year":"2007","unstructured":"Pucci, L. et al. Tissue expression and biochemical characterization of human 2-amino 3-carboxymuconate 6-semialdehyde decarboxylase, a key enzyme in tryptophan catabolism. FEBS 274, 827\u2013840 (2007).","journal-title":"FEBS"},{"key":"2793_CR78","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"561","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 561, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"2793_CR79","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ije\/dyu005","volume":"43","author":"S Burgess","year":"2014","unstructured":"Burgess, S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J. Epidemiol. 43, 922\u2013929 (2014).","journal-title":"Int J. Epidemiol."},{"key":"2793_CR80","doi-asserted-by":"publisher","first-page":"e0245638","DOI":"10.1371\/journal.pone.0245638","volume":"16","author":"S Ram","year":"2021","unstructured":"Ram, S. et al. Pixelwise H-score: a novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images. PLoS ONE 16, e0245638 (2021).","journal-title":"PLoS ONE"},{"key":"2793_CR81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/CIRCRESAHA.120.318805","volume":"129","author":"W Xiao","year":"2021","unstructured":"Xiao, W. et al. Immunometabolic endothelial phenotypes: integrating inflammation and glucose metabolism. Circ. Res. 129, 9\u201329 (2021).","journal-title":"Circ. Res."},{"key":"2793_CR82","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"A Bolger","year":"2014","unstructured":"Bolger, A. et al. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"2793_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2793_CR84","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"M Robinson","year":"2010","unstructured":"Robinson, M. et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"2793_CR85","doi-asserted-by":"publisher","unstructured":"Alexa, A. & Rahnenfuhrer, J. topGO: enrichment analysis for Gene Ontology. Bioconductor. https:\/\/doi.org\/10.18129\/B9.bioc.topGO (2023).","DOI":"10.18129\/B9.bioc.topGO"}],"updated-by":[{"DOI":"10.1038\/s41591-024-02899-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02793-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T08:26:53Z","timestamp":1726648013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02793-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2793"],"URL":"https:\/\/doi.org\/10.1038\/s41591-023-02793-8","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"16 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41591-024-02899-7","URL":"https:\/\/doi.org\/10.1038\/s41591-024-02899-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.L.H. and Z.W. report being named as co-inventors on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. S.L.H. and Z.W. also report having received royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland Heart Lab, a fully owned subsidiary of Quest Diagnostics, and Procter & Gamble. S.L.H. is a paid consultant for Zehna Therapeutics and Proctor & Gamble and has received research funds from Zehna Therapeutics, Proctor & Gamble, Pfizer and Roche Diagnostics. W.H.W.T. is a consultant for Sequana Medical A.V., Cardiol Therapeutics, Genomics plc, Zehna Therapeutics and Renovacor and has received honoraria from Springer Nature for authorship\/editorship and from the American Board of Internal Medicine for exam writing committee service. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}